This hypothesis was supported by recent reports that transgenic overexpression of APOL1 risk alleles in mouse podocytes or GECs caused podocytopathy, endotheliopathy, glomerulopathy, and clinical manifestations of kidney failure (10–14). The gene discussed is APOL1; the disease is glomerular disorder.